| Title | Therapeutic Advances in Vaccines and Immunotherapy |
| Type of Publication | Journal |
| Discipline | Drug Discovery (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2); Immunology (Q3) |
| Impact Score | 2.80 |
| SCImago Journal Rank (SJR) | 0.800 |
| h-index | 10 |
| Overall Rank | 5982 |
| Publisher Name | SAGE Publications Ltd |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 25151355, 25151363 |
| Coverage and History | 2017-2022 |
| Best Quartile | Q2 |
| Total Citations Received (Last 3 Year) |
132 |
Therapeutic Advances in Vaccines and Immunotherapy is a journal published by SAGE Publications Ltd. This journal covers the area[s] related to Drug Discovery, Immunology and Allergy, Oncology, Pharmacology (medical), Immunology, etc.
The coverage history of this journal is as follows: 2017-2022.
The rank of this journal is 5982. This journal's impact score, h-index, and SJR are 2.80, 10, and 0.800, respectively. The ISSN of this journal is/are as follows: 25151355, 25151363.
The best quartile of Therapeutic Advances in Vaccines and Immunotherapy is Q2.
This journal has received a total of 132 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Therapeutic Advances in Vaccines and Immunotherapy is 2.80. It is computed in the year 2023 as per its definition and based on Scopus data.
2.80
It is decreased by a factor of around 0.53, and the percentage change is -15.92% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Therapeutic Advances in Vaccines and Immunotherapy is 2.80. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.80 |
| 2021 | 3.33 |
| 2020 | 4.94 |
| 2019 | 4.80 |
| 2018 | 2.50 |
| 2017 | 0.00 |
The h-index of Therapeutic Advances in Vaccines and Immunotherapy is 10. By definition of the h-index, this journal has at least 10 published articles with more than 10 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Therapeutic Advances in Vaccines and Immunotherapy is/are as follows: 25151355, 25151363.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Therapeutic Advances in Vaccines and Immunotherapy is ranked 5982 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.800.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Therapeutic Advances in Vaccines and Immunotherapy is SAGE Publications Ltd. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2017-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
If your area of research or discipline is related to Drug Discovery, Immunology and Allergy, Oncology, Pharmacology (medical), Immunology, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Therapeutic Advances in Vaccines and Immunotherapy is 2.80. It is computed in the year 2023.
The latest h-index of Therapeutic Advances in Vaccines and Immunotherapy is 10. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Therapeutic Advances in Vaccines and Immunotherapy is 0.800. It is calculated in the year 2023.
The latest ranking of Therapeutic Advances in Vaccines and Immunotherapy is 5982. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Therapeutic Advances in Vaccines and Immunotherapy is published by SAGE Publications Ltd. The publication country of this journal is United Kingdom.
This standard abbreviation of Therapeutic Advances in Vaccines and Immunotherapy is .
Therapeutic Advances in Vaccines and Immunotherapy is a journal published by SAGE Publications Ltd.
The scope of Therapeutic Advances in Vaccines and Immunotherapy is as follows:
For detailed scope of Therapeutic Advances in Vaccines and Immunotherapy, check the official website of this journal.
The International Standard Serial Number (ISSN) of Therapeutic Advances in Vaccines and Immunotherapy is/are as follows: 25151355, 25151363.
The best quartile for Therapeutic Advances in Vaccines and Immunotherapy is Q2.
The coverage history of Therapeutic Advances in Vaccines and Immunotherapy is as follows 2017-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Revue Francophone des Laboratoires (discontinued) | Journal | Elsevier Masson s.r.l. | 23244 | 8 | 0.00 | |
| Journal of Geriatric Physical Therapy | Journal | Lippincott Williams and Wilkins Ltd. | 5578 | 43 | 1.80 | |
| Criminal Justice Review | Journal | SAGE Publications Inc. | 8738 | 41 | 1.30 | |
| Journal of International Financial Management and Accounting | Journal | Wiley-Blackwell Publishing Ltd | 6179 | 42 | 6.09 | |
| Canadian Journal of Education | Journal | Canadian Society for the Study of Education (CSSE) | 17961 | 41 | 0.39 | |
| Journal of Education and Work | Journal | Brill Academic Publishers | 9268 | 43 | 1.93 | |
| International Journal of Research and Method in Education | Journal | Taylor and Francis Ltd. | 5180 | 34 | 2.49 | |
| European Journal of Education | Journal | Wiley-Blackwell Publishing Ltd | 6079 | 53 | 2.31 | |
| Sex Education | Journal | Routledge | 5168 | 41 | 2.82 | |
| Archives of the Balkan Medical Union | Journal | Balkan medical union | 23243 | 10 | 0.24 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 2.80 |
| 2021 | 3.33 |
| 2020 | 4.94 |
| 2019 | 4.80 |
| 2018 | 2.50 |
| 2017 | 0.00 |
2.80
0.800
10
5982
